Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978]

doi:10.1186/1471-2466-6-3

BMC Pulmonary Medicine

Volume 6

Viewing options:

Associated material:

Readers' comments
Pre-publication history
PubMed record

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Sin DD
Man SFP
Marciniuk DD
Ford G
FitzGerald M
Wong E
York E
Mainra RR
Ramesh W
Melenka LS
Wilde E
Cowie RL
Williams D
Rousseau R

on PubMed

Sin DD
Man SFP
Marciniuk DD
Ford G
FitzGerald M
Wong E
York E
Mainra RR
Ramesh W
Melenka LS
Wilde E
Cowie RL
Williams D
Rousseau R
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Pre-publication history

Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978]

Don D Sin , SF Paul Man , Darcy D Marciniuk , Gordon Ford , Mark FitzGerald , Eric Wong , Ernest York , Rajesh R Mainra , Warren Ramesh , Lyle S Melenka , Eric Wilde , Robert L Cowie , Dave Williams and Roxanne Rousseau for the ABC (Advair, Biomarkers in COPD) Investigators

BMC Pulmonary Medicine 2006, 6:3doi:10.1186/1471-2466-6-3

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1	Manuscript		25 Nov 2005
Comment	Editor's comment		03 Jan 2006
Resubmission - Version 2	Manuscript		19 Jan 2006
Resubmission - Version 3	Manuscript	Authors' comments	03 Feb 2006
Accepted			06 Feb 2006